Immunitor LLC

Quick facts

Phase 3 pipeline

• atherosclerosis vaccine · Cardiovascular
  An immunotherapeutic vaccine that stimulates the immune system to recognize and attack oxidized lipoproteins and atherosclerotic plaques.
• hepcortespenlisimut-L · Hematology
  Hepcortespenlisimut-L is a recombinant human prohepcidin analog that stimulates the production of hepcidin, a hormone that regulates iron metabolism.
• V7 · Immunology / Infectious Disease
  V7 is an immunotherapeutic vaccine designed to stimulate the immune system against HIV infection.

Phase 2 pipeline

• Daily oral dose of hepcortespenlisimut-L · Infectious Disease / Virology
  Hepcortespenlisimut-L is an oral therapeutic vaccine that stimulates immune responses against hepatitis C virus (HCV) antigens to enhance viral clearance.
• V-Boost
• V-Endo
• V3-Cervix
• V3-MOMMO
• V3-Myoma

Phase 1 pipeline

• V-SARS
• V3-P

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Immunitor LLC portfolio CI brief
• Immunitor LLC pipeline updates RSS